|
BUD13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.12543349376438E-12 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.063400E-01 |
| Stage1-vs-Stage3 |
1.108790E-01 |
| Stage1-vs-Stage4 |
3.997300E-03 |
| Stage2-vs-Stage3 |
6.518400E-01 |
| Stage2-vs-Stage4 |
9.560400E-02 |
| Stage3-vs-Stage4 |
1.739620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.1564999996837E-07 |
| Normal-vs-Asian |
2.64669952620977E-10 |
| Caucasian-vs-AfricanAmerican |
5.360800E-01 |
| Caucasian-vs-Asian |
9.131800E-02 |
| AfricanAmerican-vs-Asian |
5.817400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.993820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.0351999996393E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.617000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.560250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.628000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.281700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.441960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.474600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.397100E-03 |
| Classical-VS-Follicular |
1.035250E-01 |
| Classical-VS-Other |
8.070200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
9.770200E-02 |
| Tall-VS-Other |
5.147000E-01 |
| Tall-VS-Normal |
1.62503344114384E-12 |
| Follicular-VS-Other |
8.563600E-01 |
| Follicular-VS-Normal |
1.64734892393881E-12 |
| Other-VS-Normal |
6.414200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.44009282066327E-15 |
| N0-vs-N1 |
1.022550E-01 |
|
|
